bosentan anhydrous has been researched along with Arthritis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barja-Fidalgo, C; Conte, Fde P; Cunha, FQ; Henriques, Md; Penido, C; Rae, GA; Verri, WA | 1 |
| Cozzi, F; Favaro, M; Marotta, H; Ostuni, PA; Sfriso, P; Todesco, S | 1 |
2 other study(ies) available for bosentan anhydrous and Arthritis
| Article | Year |
|---|---|
Endothelins modulate inflammatory reaction in zymosan-induced arthritis: participation of LTB4, TNF-alpha, and CXCL-1.
Topics: Animals; Antihypertensive Agents; Arthritis; Bosentan; Cell Movement; Chemokine CXCL1; Chemokines; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin Receptor Antagonists; Endothelin-1; Enzyme-Linked Immunosorbent Assay; Immunoblotting; Immunologic Factors; Inflammation Mediators; Knee Joint; Leukocytes; Leukotriene B4; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Neutrophil Infiltration; Neutrophils; Oligopeptides; Peptides, Cyclic; Piperidines; Receptors, Endothelin; Reverse Transcriptase Polymerase Chain Reaction; Sulfonamides; Synovial Fluid; Tumor Necrosis Factor-alpha; Vasoconstrictor Agents; Viper Venoms; Zymosan | 2008 |
Bosentan may induce arthritis flare in patients with scleroderma concomitantly treated with methotrexate.
Topics: Antihypertensive Agents; Arthritis; Bosentan; Drug Therapy, Combination; Female; Humans; Hypertension, Pulmonary; Methotrexate; Middle Aged; Scleroderma, Systemic; Sulfonamides | 2006 |